Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Device lobby hire: Elizabeth Pika moves from her post as legislative director for Rep. Tammy Baldwin, D-Wis., to become VP-government affairs at AdvaMed. Pika, replacing Seth Radus who left in May to join AdvaMed member firm Siemens, will play a particularly active role in advocating for the reform of how Medicare reimburses for molecular diagnostics in the model of the pending "Medicare Advanced Laboratory Diagnostics Act" (1"The Gray Sheet" Dec. 10, 2007, p. 13). Pika will report to Brett Loper, who joined AdvaMed in May to work with David Nexon in running the association's lobbying efforts (2"The Gray Sheet" May 5, 2008, p. 6)
Advertisement

Related Content

People In Brief
People In Brief
Financings In Brief
People In Brief
People In Brief
Industry Sees Room For Better Diagnostics Payments In Medicare Package
Industry Sees Room For Better Diagnostics Payments In Medicare Package
Advertisement
UsernamePublicRestriction

Register

MT026305

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel